| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Sr VP, Clinic Development
1 company
Roberts Brian Kenneth is a Chief Medical Officer at Rezolute, Inc.. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $971K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 28,000 | $1.70 | $47,600.00 | +10.0% | +23.3% | - | |
| Jun 25, 2025 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 2,500 | $4.38 | $10,939.00 | +19.2% | +96.8% | - | |
| Jun 14, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 7,600 | $3.91 | $29,743.17 | +6.6% | +32.2% | +6.3% | |
| May 23, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 7,500 | $2.69 | $20,137.80 | +8.7% | +42.2% | +27.1% | |
| Mar 28, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 500 | $2.55 | $1,275.00 | +86.8% | +56.9% | +14.9% | |
| Mar 14, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 10,000 | $1.88 | $18,800.00 | New | +201.1% | +97.8% | |
| Mar 7, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 500 | $1.85 | $925.00 | New | +219.9% | +112.7% | |
| Feb 26, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 8,000 | $1.69 | $13,540.00 | +10.7% | +125.0% | +154.9% | |
| Feb 16, 2024 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 7,000 | $1.31 | $9,142.00 | +25.4% | +89.6% | +241.5% | |
| Jul 3, 2023 | RZLT Rezolute, Inc. | Chief Medical Officer | Buy | 5,000 | $1.90 | $9,499.50 | +22.2% | -38.8% | +107.9% |